We are live on ! Find out more
TAM

Trillium Asset Management Portfolio holdings

AUM $3.01B
1-Year Est. Return 19.96%
This Fund
S&P 500
This Quarter Est. Return
-11.39%
1 Year Est. Return
+19.96%
3 Year Est. Return
+64.51%
5 Year Est. Return
+84.47%
10 Year Est. Return
+399.24%
AUM
$1.73B
AUM Growth
-$271M
Cap. Flow
-$13.5M
Cap. Flow %
-0.78%
Top 10 Hldgs %
20.92%
Holding
247
New
9
Increased
83
Reduced
124
Closed
17

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$7.88M
2
SEE
Sealed Air
SEE
+$6.22M
3
PX
Praxair Inc
PX
+$5.11M
4
NXPI icon
NXP Semiconductors
NXPI
+$3.85M
5
SBAC icon
SBA Communications
SBAC
+$3.85M

Sector Composition

Rank Sector Weight
1 Financials 17.16%
2 Technology 16.7%
3 Healthcare 14.37%
4 Consumer Discretionary 10.82%
5 Industrials 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WST icon
176
West Pharmaceutical
WST
$24.4B
$1.16M 0.07%
11,807
+461
+4% +$50K
EGP icon
177
EastGroup Properties
EGP
$11B
$1.12M 0.06%
12,255
+637
+5% +$61.4K
SCHH icon
178
Schwab US REIT ETF
SCHH
$11.4B
$1.11M 0.06%
57,620
-2,566
-4% -$52.4K
JPM icon
179
JPMorgan Chase
JPM
$961B
$1.05M 0.06%
10,751
+623
+6% +$66.4K
MAN icon
180
ManpowerGroup
MAN
$2.5B
$1M 0.06%
15,509
+104
+0.7% +$7.9K
TLRD
181
DELISTED
Tailored Brands, Inc.
TLRD
$991K 0.06%
72,652
+2,697
+4% +$55.6K
CTXS
182
DELISTED
Citrix Systems Inc
CTXS
$990K 0.06%
9,666
-2,912
-23% -$308K
BDN
183
Brandywine Realty Trust
BDN
$543M
$966K 0.06%
75,088
+1,845
+3% +$26.1K
EGBN icon
184
Eagle Bancorp
EGBN
$863M
$933K 0.05%
19,162
+400
+2% +$20.4K
CERN
185
DELISTED
Cerner Corp
CERN
$891K 0.05%
16,996
-2,122
-11% -$123K
TKR icon
186
Timken Company
TKR
$9.08B
$675K 0.04%
+18,100
New +$732K
NOV icon
187
NOV
NOV
$7.13B
$652K 0.04%
25,365
-1,442
-5% -$49.8K
GWW icon
188
W.W. Grainger
GWW
$60.9B
$642K 0.04%
2,273
+69
+3% +$20.5K
WT icon
189
WisdomTree
WT
$3.32B
$638K 0.04%
95,928
-3,492
-4% -$25.4K
FITB
190
Fifth Third Bancorp
FITB
$52.4B
$626K 0.04%
26,590
-74
-0.3% -$1.95K
LGND icon
191
Ligand Pharmaceuticals
LGND
$5.92B
$595K 0.03%
7,031
+274
+4% +$29.2K
ZBH icon
192
Zimmer Biomet
ZBH
$18.4B
$557K 0.03%
5,527
-3,403
-38% -$383K
PFE icon
193
Pfizer
PFE
$144B
$536K 0.03%
12,944
-1,884
-13% -$78.2K
SEE
194
DELISTED
Sealed Air
SEE
$521K 0.03%
14,957
-178,185
-92% -$6.22M
IBM icon
195
IBM
IBM
$216B
$500K 0.03%
4,604
-60
-1% -$7.2K
PPG icon
196
PPG Industries
PPG
$26B
$477K 0.03%
4,670
BRK.B icon
197
Berkshire Hathaway Class B
BRK.B
$1.11T
$476K 0.03%
2,329
+73
+3% +$15.2K
INTC icon
198
Intel
INTC
$499B
$471K 0.03%
10,032
+2,210
+28% +$103K
NVO
199
Novo Nordisk
NVO
$209B
$455K 0.03%
19,758
-2,910
-13% -$64.7K
SPN
200
DELISTED
Superior Energy Services, Inc.
SPN
$444K 0.03%
13,266
-1,141
-8% -$79.3K

Similar funds

Trillium Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Trillium Asset Management held 247 positions worth $1.73B, down 14% from $2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trillium Asset Management's Q4 2018 filing shows 9 new, 83 increased, 124 reduced and 17 closed positions. Its largest new stake was Air Products & Chemicals: 46,551 shares worth $7.45M. The largest sale was Hologic, an estimated $7.88M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • Trillium Asset Management's largest Q4 2018 buy was Air Products & Chemicals: 46,551 shares worth $7.45M.
  • Trillium Asset Management added most to iShares MSCI KLD 400 Social ETF in Q4 2018, an estimated $13.7M increase.
  • Trillium Asset Management's biggest Q4 2018 reduction was Hologic, cutting an estimated $7.88M.
  • Trillium Asset Management fully exited Praxair Inc in Q4 2018, selling an estimated $5.11M.
  • Trillium Asset Management's ten largest holdings make up 21% of its $1.73B portfolio in Q4 2018.
  • Trillium Asset Management opened 9 new positions and closed 17 in Q4 2018.
  • Trillium Asset Management's portfolio value fell 14% quarter-over-quarter to $1.73B.

Based on Trillium Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.